Fluoguide A S Nasdaq Fluo
FluoGuide is a clinical-stage biotech company specializing in precision cancer surgery. Our mission is to improve outcomes for cancer patients by helping surgeons remove cancer more accurately. Our lead product, FG001, has been clinically proven to light up cancer during surgery, guiding more precise removal while preserving healthy tissue. FG001 has shown strong results in brain, head and neck, and lung cancers, and is well-tolerated by patients. Scientific data and clinical experience suggest its broad potential across solid tumor types. Strategic partnerships with surgical equipment manufacturers support integration and wide adoption of FG001 in the operating room. FluoGuide is listed on the Nasdaq First North Growth Market in Stockholm under the ticker symbol "FLUO." For more information about FluoGuide's pipeline, technology, and upcoming events, visit
7-day free trial · no credit card
Verified contacts
6
available on Kipplo
LinkedIn employees
15
1 to 10 range
Open roles
—
no listings
Distinct roles
5
indexed titles
Tech stack
1
tools in use
Monthly traffic
22
organic / mo
Sign up free to see all 6 verified contacts at Fluoguide A S Nasdaq Fluo
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
6 contacts with verified email or phone · masked until revealed.
- DH
Donna Haire
Bioporto a s · Other
EmailPhone
Showing 1 of 6 verified contacts
Top roles at Fluoguide A S Nasdaq Fluo
5 distinct titles indexed · top 5 shown.
- 1bioporto a s
- 1clinical operations assistant
- 1fluoguide a s (nasdaq fluo)
- 1investor relations manager
- 1qa senior manager
Sign up to unlock all 6 contacts at Fluoguide A S Nasdaq Fluo
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 6 verified contacts at Fluoguide A S Nasdaq Fluo
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.